SCHEMBL7667553

SCHEMBL7667553

CC(CC(=O)O)O[Si](C(C)C)(C(C)C)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.35
CACNA2D1 P54289 2/20 0.33
CACNB3 P54284 1/20 0.33
CACNA1C Q13936 1/20 0.33
PGR P06401 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR2B P41595 1/20 0.33
CACNA2D2 Q9NY47 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALOX15 P16050 1/20 0.31
HTT P42858 1/20 0.31
GABRR1 P24046 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7667545 1.00 SMN1; SMN2 (0.37) SMN1; SMN2SLC22A6CACNA2D1CACNB3CACNA1C
SCHEMBL9651906 1.00 SMN1; SMN2 (0.37) SMN1; SMN2SLC22A6CACNA2D1CACNB3CACNA1C
SCHEMBL9651309 0.80 CA2 (0.30)
SCHEMBL7668711 0.80 CA2 (0.30)
SCHEMBL7668714 0.80 CA2 (0.30)
SCHEMBL9652086 0.78 TSHR (0.37) MAPT
SCHEMBL9652087 0.77 LMNA (0.34) SMN1; SMN2SLC22A6TDP1MAPTALDH1A1
SCHEMBL7254593 0.76 SLC22A6 (0.33) SMN1; SMN2SLC22A6CACNA2D1CACNB3CACNA1C
SCHEMBL13297198 0.75 FNTA (0.36) MAPT
SCHEMBL31341290 0.75 GABRP (0.38) SLC22A6ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6387934-B1 RHEUMATIC DISEASES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-05-14 US disclosed
US-6172103-B1 TREATING BONE DISORDERS, OSTEOPOROSIS, AND ARTHRITIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-01-09 US disclosed
US-6121316-A BONE DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 2000-09-19 US disclosed
US-5145957-A Carbapenicillin intermediates MERCK & CO., INC. (US) 1992-09-08 US disclosed
EP-0333268-A1 Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone MERCK & CO. INC. (US) 1989-09-20 EP disclosed